Asset Management One’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,608
Closed -$193K 990
2024
Q4
$193K Sell
7,608
-420
-5% -$10.6K ﹤0.01% 880
2024
Q3
$200K Sell
8,028
-461
-5% -$13.7K ﹤0.01% 878
2024
Q2
$252K Sell
8,489
-135
-2% -$3.75K ﹤0.01% 865
2024
Q1
$260K Sell
8,624
-7,454
-46% -$207K ﹤0.01% 888
2023
Q4
$461K Sell
16,078
-429
-3% -$12.6K ﹤0.01% 856
2023
Q3
$612K Sell
16,507
-7,268
-31% -$278K ﹤0.01% 853
2023
Q2
$927K Sell
23,775
-775
-3% -$30.4K ﹤0.01% 832
2023
Q1
$896K Sell
24,550
-1,591
-6% -$50.2K ﹤0.01% 840
2022
Q4
$812K Buy
+26,141
New +$811K ﹤0.01% 848

Other funds holding RTO

Asset Management One's RTO Position: Q1 2025 in Review

Asset Management One sold out of Rentokil (RTO) in Q1 2025, closing a stake of 7,608 shares — an estimated $193K sold.

Asset Management One first reported a position in RTO in Q4 2022 and held it in 9 quarters. The position peaked at $927K in Q2 2023. 209 funds tracked by Wall St. Rank hold RTO as of Q1 2025.

  • Asset Management One reported no remaining Rentokil position as of Q1 2025 after selling out during the quarter.
  • Asset Management One sold 7,608 Rentokil shares in Q1 2025, an estimated $193K.
  • Asset Management One first reported a position in Rentokil in Q4 2022 and held it in 9 quarters.
  • Asset Management One's Rentokil position peaked at $927K in Q2 2023.
  • 209 funds tracked by Wall St. Rank held Rentokil as of Q1 2025.

Based on Asset Management One's 13F filing for Q1 2025, filed 23 Apr 2025.